Advanced Search
XIE Qing-xiang, ZHANG Yang-gen, HAN Cong-xiang, XU Zhong-yi, HUANG Hong-wei, LI Jin-yu, LIN Xia-cong. Clinical Value of Urine Soluble Fas and Soluble Fas Ligand in Bladder Cancer[J]. Cancer Research on Prevention and Treatment, 2004, 31(05): 252-254. DOI: 10.3971/j.issn.1000-8578.2011
Citation: XIE Qing-xiang, ZHANG Yang-gen, HAN Cong-xiang, XU Zhong-yi, HUANG Hong-wei, LI Jin-yu, LIN Xia-cong. Clinical Value of Urine Soluble Fas and Soluble Fas Ligand in Bladder Cancer[J]. Cancer Research on Prevention and Treatment, 2004, 31(05): 252-254. DOI: 10.3971/j.issn.1000-8578.2011

Clinical Value of Urine Soluble Fas and Soluble Fas Ligand in Bladder Cancer

  • Objective To examine the level of soluble Fas (sFas) and soluble Fas ligand (sFasL) in urine of patients with bladder cancer and to investigate their clinical value. Methods Enzyme linked immunosorbent assays (ELISA) was available to detect the level of sFas and sFasL in urine of 43 patients with bladder cancer and 12 cases of normal control. Results The urine level of sFas and sFasL in bladder cancer were significantly higher than those in normal control,respectively. Level of sFas was positive associatio...
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return